Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma. International journal

Kawakubo N, Tanaka S, Kinoshita Y, Tajiri T, Yonemitsu Y, Taguchi T.

Journal of Pediatric Surgery   2018.8

The current status of nursing professionalism in the nursing faculty in Japan. International journal

Tanaka M, Taketomi K, Yonemitsu Y, Kawamoto R.

The Journal of Nursing Research   2017.2

Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis. International journal

Takahashi H, Shimodaira S, Ogasawara M, Ota S, Kobayashi M, Abe H, Morita Y, Nagai K, Tsujitani S, Okamoto M, Suzuki Y, Nakanishi Y, Yonemitsu Y.

Cancer Immunology, Immunotherapy   2016.9

BubR1 insufficiency results in decreased macrophage proliferation and attenuated atherogenesis in apolipoprotein E-deficient mice. International journal

Tanaka S, Matsumoto T, Matsubara Y, Harada Y, Kyuragi R, Koga J, Egashira K, Nakashima Y,Yonemitsu Y, Maehara Y.

Journal of the American Heart Association   2016.9

Improved quality of life in patients with no-option critical limb ischemia undergoing gene therapy with DVC1-0101. International journal

Matsumoto T, Tanaka M, Yoshiya K, Yoshiga R, Matsubara Y, Yoshida K, Yonemitsu Y, Maehara Y.

Scientific Reports   2016.7

Peritoneal dissemination requires an Sp1-dependent CXCR4/CXCL12 signaling axis and extracellular matrix-directed spheroid formation. International journal

Kasagi Y, Harada Y, Morodomi Y, Saito S, Yoshida K, Oki E, Saeki K, Ohgaki K, Sugiyama M, Onimaru M, Maehara Y, Yonemitsu Y.

Cancer Research   2016.1

Professional behaviors and factors contribute to nursing professionalism among nurse managers. International journal

Tanaka M, Taketomi K, Yonemitsu Y, Kawamoto R.

Journal of Nursing Management   2016.1

The relationship between characteristics of nursing performance and years experience in nurses with high emotional intelligence. International journal

Fujino Y, Tanaka M, Yonemitsu Y, Kawamoto R.

International Journal of Nursing Practice   2015.12

Effective recovery of highly purified CD326+ tumor cells from lavage fluid of patients treated with a novel cell-free and concentrated ascites reinfusion therapy (KM-CART). International journal

Kimura Y, Harada Y, Yasuda N, Ishidao T, Yusa S, Matsusaki K, Yonemitsu Y.

SpringerPlus   2015.12

Dendritic cell-based immunotherapy targeting Wilms' Tumor 1 (WT1) in patients with relapsed malignant glioma. International journal

Sakai K, Shimodaira S, Maejima S, Udagawa N, Sano K, Higuchi Y, Koya T, Suigiyama H, Yonemitsu Y, Okamoto M, Hongo K.

Journal of Neurosurgery   2015.10

BubR1 insufficiency impairs vascular smooth muscle cell proliferation and inhibits neointimal hyperplasia in mice. International journal

Kyuragi R, Matsumoto T, Harada Y, Saito S, Onimaru M, Nakatsu Y, Tsuzuki T, Nomura M, Yonemitsu Y, Maehara Y.

Arterioscler Theromb Vasc Biol   2015.2

An international comparison of professional behaviors between U.S. and Japanese nurse leaders. International journal

Tanaka M, Yonemitsu Y, Kawamoto R.

International Journal of Nursing and Clinical Practice   2015.2

The apelin–APJ system induces tumor arteriogenesis in hepatocellular carcinoma. International journal

2014.10

Nursing Professionalism: a national survey of professional behaviors contributing Japanese nurses. International journal

Tanaka M, Yonemitsu Y, Kawamoto R.

International Journal of Nursing Practice   2014.10

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer. International journal

Kobayashi M, Chiba A, Izawa H, Yanagida E, Okamoto M, Shimodaira S, Yonemitsu Y, Shibamoto Y, Suzuki N, Nagaya M.

Journal of Ovarian Research   2014.5

Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis. International journal

Kobayashi M, Shimodaira S, Nagai K, Ogasawara M, Takahashi H, Abe H, Tanii M, Okamoto M, Tsujitani S, Yusa S, Ishidao T, Kishimoto J, Shibamoto Y, Nagaya M, Yonemitsu Y.

Cancer Immunology, Immunotherapy   2014.4

Impact of dendritic cell vaccines pulsed with Wilms’ tumor-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers. International journal

2013.12

Ex vivo generation of highly purified and activated NK cells from human peripheral blood. Invited Reviewed International journal

Saito S, Harada Y, Morodomi Y, Onimaru M, Yoshida K, Matsubara H, Yonemitsu Y.

Human Gene Therapy Method   2013.8

Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer. International journal

Kobayashi M, Sakabe T, Abe H, Tanii M, Takahashi H, Chiba A, Yanagida E, Shibamoto Y, Ogasawara M, Tsujitani S, Koido S, Nagai K, Shimodaira S, Okamoto M, Yonemitsu Y, Suzuki N, Nagaya M.

Journal of Gastrointestinal Surgery   2013.7

DVC1-0101 to treat peripheral arterial disease: Phase I/IIa, open-label, dose escalation clinical trial. International journal

Yonemitsu Y, Matsumoto T, Itoh H, Okazaki J, Uchiyama M, Yoshida K, Onimaru M, Onohara T, Inoguchi H, Kyuragi R, Guntani A, Shimokawa M, Ban H, Inoue M, Zhu T, Hasegawa M, Nakanishi Y, Maehara Y.

Molecular Therapy   2013.1

Endogenous cardiac troponin T modulates Ca2+ -mediated smooth muscle contraction International journal

Nakayama S, Kajioka S, Takahashi-Yanaga F, Shahab N, Onimaru M, Matsuda M, Takahashi R, Asano H, Morita H, Morimoto S, Yonemitsu Y, Hayashi M, Seki N, Sasaguri T, Hirata M, Naito S.

Scientific Reports   2012.12

MutT homolog-1 attenuates oxidative DNA damage and delays photoreceptor death in murine inherited retinal degeneration International journal

Murakami Y, Ikeda Y, Yoshida N, Notomi S, Hisatomi T, Oka S, De Luca G, Yonemitsu Y, Bignami M, Nakabeppu Y, Ishibashi T.

American Journal of Pathology   2012.7

A somatostatin analogue octreotide ameliorates intestinal ischemia-reperfusion injury through the early induction of heme oxygenase-1 International journal

Takano T, Yonemitsu Y, Itoh H, Matsumoto T, Onohara T, Takai M, Maehara Y.

Journal of Surgical Research   2012.6

BioKnife, a uPAR-targeted oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression International journal

Morodomi Y, Yano T, Kinoh H, Harada Y, Saito S, Kyuragi R, Yoshida K, Onimaru M, Shoji F, Yoshida T, Ito K, Shikada Y, Maruyama R, Hasegawa M, Maehara Y, Yonemitsu Y.

2012.4

Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in the patients with advanced pancreatic carcinoma. International journal

Kimura Y, Tsukada J, Tomoda T, Takahashi H, Imai K, Shimamura K, Sunamura M, Yonemitsu Y, Shimodaira S, Koido S, Homma S, Okamoto M.

Pancreas   2012.3

Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells International journal

Harada Y, Ueda Y, Tsujitani S, Saito S, Iida A, Hasegawa M, Ichikawa T, Yonemitsu Y.

Scientific Reports   2011.11

Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Ab1-43/IL-10 cDNA International journal

Hara H, Mouri A, Yonemitsu Y, Nabeshima T, Inoue M, Tabira T.

Vaccine   2011.10

Complete elimination of established neuroblastoma by synergistic action of γ-irradiation and DCs treated with rSeV expressing interferon-β gene. International journal

2011.7

Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism for pigment epithelium-derived factor-mediated neuroprotection in retinal degeneration International journal

Murakami Y, Ikeda Y, Yonemitsu Y, Onimaru M, Nakagawa K, Kohno R-I, Miyazaki M, Nakamura M, Yabe T, Hasegawa M, Ishibashi T, Sueishi K.

The American Journal of Pathology   2011.7

Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascitis International journal

Sugiyama M, Kakeji Y, Tsujitani S, Harada Y, Onimaru M, Yoshida K, Tanaka S, Emi Y, Morita M, Morodomi Y, Hasegawa M, Maehara Y, Yonemitsu Y.

Molecular Cancer Therapeutics   2011.1

Semi-Allogeneic dendritic cells injected via the intratumoural injection route show efficient antitumour effects in cooperation with host-derived professional antigen-presenting cells. International journal

Kondo H, Okano S, Yoshida Y, Yonemitsu Y, Tomita Y, Yoshikai Y, Wake N, Sueishi.

The Scandinavian Journal of Immunology   2010.12

RIG-I helicase-independent pathway in Sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer. International journal

Kato T, Ueda Y, Kinoh H, Yoneyama Y, Matsunaga A, Komaru A, Harada Y, Suzuki H, Komiya A, Shibata S, Hasegawa M, Hayashi H, Ichikawa T, Yonemitsu Y.

Neoplasia   2010.11

Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells. International journal

Suzuki H, Onimaru M, Yonemitsu Y, Maehara Y, Nakamura S, Sueishi K.

Molecular Cancer   2010.10

Carbon ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma. International journal

Matsunaga A, Ueda Y, Yamada S, Ishida K, Yoneyama Y, Kato T, Harada Y, Shibata S, Shimada H, Inoue M, Hasegawa M, Tsuji H, Ochiai T, Yonemitsu Y.

Cancer   2010.8

Urokinase-targeted cell-cell fusion by oncolytic Sendai virus eradicates orthotropic model of glioblastomas by a pronounced synergy with interferon-β. International journal

2010.7

PEDF gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal models. International journal

Miyazaki M, Ikeda Y, Yonemitsu Y, Goto Y, Murakami Y, Tabata T, Hasegawa M, Tobimatsu S, Sueishi K, Tatsuro Ishibashi.

Human Gene Therapy   2010.3

Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai virus envelope proteins. International journal

Murakami Y, Ikeda Y, Yonemitsu Y, Miyazaki M, Inoue M, Hasegawa M, Sueishi K, Ishibashi T.

Human Gene Therapy   2010.2

An autocrine linkage between matrix metalloproteinase-14 and Tie-2 via ectodomain shedding modulates angiopoietin-1 dependent function in endothelial cells. International journal

Onimaru M, Yonemitsu Y, Suzuki H, Fujii T, Sueishi K.

Arterioscler Thromb Vasc Biol   2010.1

VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B. International journal

Onimaru M, Yonemitsu Y, Fujii T, Tanii M, Nakano T, Nakagawa K, Kohno R, Hasegawa M, Nishikawa SI, Sueishi K.

Am J Physiol, Heart Circ Physiol   2009.11

Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies. International journal

Kinoh H, Inoue M, Komaru A, Ueda Y, Hasegawa M, Yonemitsu Y.

Gene Therapy   2009.11

Sustained and NK/CD4+T-cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus. International journal

Komaru A, Ueda Y, Furuya A, Tanaka S, Yoshida K, Kato T, Kinoh H, Harada Y, Suzuki H, Inoue M, Hasegawa M, Ichikawa T, Yonemitsu Y.

The Journal of Immunology   2009.9

Acute safety study of simian immunodeficiency virus from African green monkey (SIVagm)-based lentiviral vector for retinal gene transfer in nonhuman primates. International journal

Ikeda Y, Yonemitsu Y, Miyazaki M, Kohno RI, Murakami Y, Murata T, Tabata T, Ueda Y, Ono F, Suzuki T, Ageyama N, Terao K, Hasegawa M, Sueishi K, Ishibashi T.

Human Gene Therapy   2009.9

Autocrine loop between VEGF-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. International journal

Matsuura M, Onimaru M, Yonemitsu Y, Nakano T, Suzuki H, Ishibashi H, Shirasuna H, Sueishi K.

The American Journal of Pathology   2009.9

Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. International journal

Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Himeno K, Hisaeda H.

Vaccine   2009.8

Cytokine-based log-scale expansion of functional murine dendritic cells. International journal

Harada Y, Ueda Y, Kinoh H, Komaru A, Fuji-Ogawa T, Furuya A, Iida A, Hasegawa M, Ichikawa T, Yonemitsu Y.

PLoS ONE   2009.8

Stable retinal gene expression in nonhuman primates via subretinal injection of SIVagm-based lentiviral vectors. International journal

Ikeda Y, Yonemitsu Y, Miyazaki M, Kohno RI, Murakami Y, Murata T, Tabata T, Ueda Y, Ono F, Suzuki T, Ageyama N, Terao K, Hasegawa M, Sueishi K, Ishibashi T.

Human Gene Therapy   2009.6

Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. International journal

Taniguchi K, Sasaki K, Watari K, Yasukawa H, Imaizumi T, Ayada T, Okamoto F, Ishizaki T, Kato R, Kohno R, Kimura H, Sato Y, Ono M, Yonemitsu Y, Yoshimura A.

PLoS ONE.   2009.5

Synergistic neuroprotective effect via simian lentivirus-mediated simultaneous gene transfer of PEDF and FGF-2 in rodent models of retinitis pigmentosa. International journal

Miyazaki M, Ikeda Y, Yonemitsu Y, Goto Y, Kohno RI, Murakami Y, Sakamoto T, Inoue M, Ueda Y, Hasegawa M, Tobimatsu S, Ishibashi T.

The Journal of Gene Medicine   2008.12

Non-transmissible SeV encoding GM-CSF is a novel and potent vector system to produce autologous tumor vaccines. International journal

Inoue H, Iga M, Xin M, Asai S, Nabeta H, Kurita R, Nakayama M, Suehiro Y, Okano S, Inoue M, Katagiri T, Takayama K, Yonemitsu Y, Hasegawa M, Nakamura Y, Nakanishi Y, Tani K.

Cancer Science   2008.10

Statins restore blood flow of ischemic limb in diabetic microangiopathy via upregulation of eNOS/NO, but not via PDGF-BB expression. International journal

Fujii T, Onimaru M, Yonemitsu Y, Kuwano H, Sueishi K.

Am J Physiol, Heart Circ Physiol   2008.4

VEGF Function for Upregulation of Endogenous PlGF Expression during FGF-2-mediated Therapeutic Angiogenesis. International journal

Fujii T, Yonemitsu Y, Onimaru M, Inoue M, Hasegawa M, Kuwano H, Sueishi K.

Atherosclerosis   2008.2

Newly developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes. International journal

Murakami Y, Ikeda Y, Yonemitsu Y, Tanaka S, Kondo H, Okano S, Kohno RI, Miyazaki M, Inoue M, Hasegawa M, Ishibashi T, Sueishi K.

The Journal of Gene Medicine   2008.2

In vivo repopulation of cytoplasmically gene-transferred hematopoietic cells by temperature sensitive mutant of recombinant Sendai viral vector. International journal

Yoshida K, Yonemitsu Y, Tanaka S, Yoshida S, Shibata S, Kondo H, Okano S, Ishikawa F, Akashi K, Inoue M, Hasegawa M, Sueishi K.

Biochemical and Biophysical Research Communications   2007.7

In vivo reduction of nuclear factor-κB activity using synthetic cis-element decoy oligonucleotides suppresses intimal hyperplasia of injured rabbit carotid arteries. International journal

2007.7

Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor-3 signaling. International journal

Taniguchi K, Kohno R, Ayada T, Kato R, Morisada T, Oike Y, Yonemitsu Y, Maehara Y, Yoshimura A.

Molecular and Cellular Biology   2007.4

Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells. International journal

Yoneyama Y, Ueda Y, Akutsu Y, Matsunaga A, Shimada H, Kato T, Kubota-Akizawa M, Okano S, Shibata S, Sueishi K, Hasegawa M, Ochiai T, Yonemitsu Y.

Biochemical and Biophysical Research Communications   2007.2

Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice International journal

Tanaka S, Yonemitsu Y, Yoshida K, Okano S, Kondo H, Inoue M, Hasegawa M, Matsumoto K, Suita S, Taguchi T, Sueishi K.

Gene Therapy   2007.1

Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling. International journal

Taniguchi K, Ayada T, Ichiyama K, Kohno R, Yonemitsu Y, Minami Y, Kikuchi A, Maehara Y, Yoshimura A.

Biochemical and Biophysical Research Communications   2007.1

Non-endothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization - critical role of the inflammatory/arteriogenic pathway International journal

Fujii T, Yonemitsu Y, Tanii M, Nakano T, Egashira K, Takehara T, Inoue M, Hasegawa M, Kuwano H, Sueishi K.

Arterioscler Thromb Vasc Biol   2006.11

Ex vivo electroporation as a potent new strategy for non-viral gene transfer into autologous vein grafts International journal

Yamaoka T, Yonemitsu Y, Komori K, Baba H, MatsumotoT, Onohara T, Maehara Y.

Am J Physiol, Heart Circ Physiol   2006.11

The regulation of vascular endothelial growth factors (VEGF-A, -C, and -D) expression in the retinal pigment epithelium. International journal

Ikeda Y, Yonemitsu Y, Onimaru M, Nakano T, Miyazaki M, Kohno R, Nakagawa K, Ueno A, Sueishi K, Ishibashi T.

Experimental Eye Research   2006.11

Actions of ZD0947, a novel ATP-sensitive K+ channel opener, on membrane currents in human detrusor myocytes. International journal

Aishima M, Tomoda T, Yunoki T, Nakano T, Seki N, Yonemitsu Y, Sueishi K, Naito S, Ito Y, Teramoto N.

The British Journal of Pharmacology   2006.11

Induction of efficient antitumor immunity using dendritic cells activated by Sendai virus and its modulation of exogenous interferon-β gene. International journal

2006.9

Critical Roles of memory T-cells and anti-donor immunoglobulin in rejection of allogenic bone marrow cells in sensitized recipient mice. International journal

Nagata S, Okano S, Yonemitsu Y, Nakagawa K, Shoji F, Hashimoto R, Tomita Y, Yoshikai Y, Shimada M, Maehara Y, Sueishi K.

Transplantation   2006.9

Sphere formation of ocular epithelial cells in ciliary body is a reprogramming system for neural differentiation International journal

Kohno RI, Ikeda Y, Yonemitsu Y, Hisatomi T, Yamaguchi M, Miyazaki M, Ishibashi T, Sueishi K.

Brain Research   2006.6

Tumor necrosis factor-α antisense transfer remarkably improves hepatic graft viability. International journal

2006.5

A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephrophathic metabolic syndrome in severe hind limb ischemia. International journal

Kaneko K, Yonemitsu Y, Fujii T, Onimaru M, Inoue M, Hasegawa M, Onohara T, Maehara Y, Sueishi K.

Am J Physiol, Heart Circ Physiol   2006.4

The effects of flavoxate hydrochloride on voltage-dependent L-type Ca2+ currents in human urinary bladder. International journal

Tomoda T, Aishima M, Takano N, Nakano T, Seki N, Yonemitsu Y, Sueishi K, Naito S, Ito Y, Teramoto N.

The British Journal of Pharmacology   146 ( 1 )   25 - 32   2005.9

PDGF-AA is an essential and autocrine regulator of VEGF expression in non-small cell lung carcinomas. International journal

Shikada Y, Yonemitsu Y, Koga T, Onimaru M, Okano S, Saata S, Nakagawa K, Yoshino I, Maehara Y, Sueishi K.

Cancer Research   2005.8

Vascular enbdothelial growth factor induced angiogenesis after transformation of E. Coli– An alternative gene therapy. International journal

2005.7

Cytoplasmic expression and extracellular deposition of an antiangiogenic factor, PEDF, in human atherosclerotic plaques. International journal

Baba H, Yonemitsu Y, Nakano T, Miyazaki M, Ikeda Y, Sumiyoshi S, Ueda Y, Hasegawa M, Yoshino I, Maehara Y, Sueishi K.

Arterioscler Thromb Vasc Biol   25 ( 9 )   1938 - 1944   2005.6

Angiogenesis/lymphangiogenesis and expression of lymphangiogenic factors in atherosclerotic intima of human coronary arteries. International journal

Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y, Ishii T, Iida M, Sueishi K.

Human Pathology   36 ( 4 )   330 - 340   2005.4

SOCS1 inhibits HPV-E7 mediated transformation by inducing degradation of E7 protein. International journal

Kamio M, Yoshida T, Ogata H, Douchi T, Nagata Y, Inoue M, Hasegawa M, Yonemitsu Y, Yoshimura A.

Oncogene   2004.12

Blockade of Vascular Endothelial Growth Factor Suppresses Experimental Restenosis After Intraluminal Injury by Inhibiting Recruitment of Monocyte Lineage Cells. International journal

Ohtani K, Egashira K, Hiasa KI, Zhao Q, Kitamoto S, Ishibashi M, Usui M, Inoue S, Yonemitsu Y, Sueishi K, Sata M, Shibuya M, Sunagawa K.

Circulation   110 ( 16 )   2444 - 2452   2004.10

Growth pattern correlates with the distribution of basement membrane and prognosis in lung adenocarcinoma. International journal

Matsuo Y, Hashimoto S, Koga T, Yonemitsu Y, Yoshino I, Sugimachi K, Masuda K, Sueishi K.

Pathology Research and Practice   200 ( 7-8 )   517 - 529   2004.7

The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization. International journal

Miyoshi K, Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M, Hasehawa M, Yonemitsu Y, Komiya S, Yoshimura A.

Oncogene   23 ( 33 )   5567 - 5576   2004.7

The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization. International journal

Miyoshi K, Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M, Hasehawa M, Yonemitsu Y, Komiya S, Yoshimura A.

Oncogene   23 ( 33 )   5567 - 5576   2004.7

Essential role of PDGFRα/p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRα/p70S6K during angiogenesis. International journal

94 ( 9 )   1186 - 1194   2004.5

Plaque-stabilizing effect of Pitabastatin in Watanabe heritable hyperlipidemic rabbits. International journal

Suzuki H, Kobayashi H, Sato F, Yonemitsu Y, Nakashima Y, Sueishi K.

Journal of Atherosclerosis and Thrombosis   2003.10

Simian Immunodeficiency Virus-Based Lentiviral Vector For Retinal Gene Transfer: a preclinical safety International journal

Ikeda Y, Goto Y (equal contribution), Yonemitsu Y, Miyazaki M, Sakamoto T, Ishibashi T, Ueda Y, Hasegawa M, Tobimatsu S, Sueishi K.

Gene Therapy   10 ( 14 )   1161 - 1169   2003.9

Recombinant Sendai virus vectors for activated T-lymphocytes International journal

Okano S, Yonemitsu Y, Nagata S, Sata S, Nakagawa K, Tomita Y, Nakashima Y, Hasegawa M, Sueishi K.

Gene Therapy   10 ( 16 )   1381 - 1391   2003.8

In vivo delivery of glial cell-derived neurotrophic factor across blood-brain barrier by gene transfer into International journal

Jiang C, Koyabu N, Yonemitsu Y, Shimazoe T, Watanabe S, Naito M, Tsuruo T, Ohtani H, Sawada Y.

Human Gene Therapy   14 ( 12 )   1181 - 1191   2003.8

Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects International journal

Miyazaki M, Ikeda Y, Yonemitsu Y, Goto Y, Sakamoto T, Tabata T, Ueda Y, Hasegawa M, Tobimatsu S, Ishibashi T, Sueishi K.

Gene Therapy   10 ( 17 )   1503 - 1511   2003.8

Intramuscular gene transfer of FGF-2 attenuates regenerative endothelial dysfunction and inhibits International journal

Shoji T, Yonemitsu Y, Komori K, Tanii M, Itoh H, Sata S, Shimokawa H, Hasegawa M, Sueishi K, Maehara Y.

American Journal of Physiology   285 ( 1 )   H173 - H182   2003.7

Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplantation bronchiolitis obliterans in mice. International journal

Shoji F, Yonemitsu Y, Okano S, Yoshino I, Nakagawa K, Nakashima Y, Hasegawa M, Sugimachi K, Sueishi K.

Gene Therapy   10 ( 3 )   213 - 218   2003.2

Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells. International journal

Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, Takeshita H, Hasegawa M, Sueishi K, Hara T.

Gene Therapy   10 ( 3 )   272 - 277   2003.2

FGF-2 gene transfer can stimulate HGF expression, irrespective of hypoxia-mediated downregulation in ischemic limbs. International journal

Onimaru M, Yonemitsu Y, Nakagawa K, Masaki I, Tanii M, Okano S, Shirasuna K, Hasegawa M, Sueishi K.

Circulation Research   2002.11

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Pulmonary Hypertension in Rats

Ikeda Y, Yonemitsu Y, Kataoka C, Kitamoto S, Nishida S, Takeshita A, Egashira K, Sueishi K.

American Journal of Physiology   283 ( 5 )   H2021 - H2028   2002.11

Recombinant Sendai virus-mediated gene transfer to the retinal tissue of adult rats: efficient gene transfer by brief exposure. International journal

Ikeda Y, Yonemitsu Y, Ishibashi T, Murata T, Ueno H, Kato A, Nagai Y, Fukumura M, Inomata H, Hasegawa M, Sueishi K.

Experimental Eye Research   75 ( 1 )   39 - 48   2002.7

Gene transfer into brain capillary endothelial cells in vitro and in vivo with HVJ-liposomes.

Jiang C, Matsuo H, Koyabu N, Ohtani H, Fujimoto H, Yonemitsu Y, Kaneda Y, Naito M, Tsuruo T, Sawada Y.

The Journal of Drug Targeting   2002.7

Effects of sevoflurane on bradykinin-induced calcium mobilization in pulmonary arterial valvular endothelial cells in situ: : Sevoflurane Stimulates Plasmalemmal Calcium Influx Into Endothelial Cells

Kanna T, Akata T, Izumi K, Yonemitsu Y, Hashizume M, Takahashi S.

The Journal of Cardiovascular Pharmacology   2002.7

Intraluminal gene transfer of endothelial nitric oxide synthase partially supresses neointimal formation of vein grafts of hypercholesterolemic rabbits: a limited biological effect as a result of the loss of medial smooth muscle cells. International journal

Ohta S, Komori K, Yonemitsu Y, Onohara T, Matsumoto T, Sugimachi K.

Surgery   131 ( 6 )   644 - 653   2002.6

Gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of VEGF165, but not of FGF-2.

Masaki I, Yonemitsu Y (equal contribution), Yamashita A, Sata S, Komori K, Fukumura M, Hou X, Hasegawa M, Sugimachi K, Sueishi K.

Circulation Research   2002.5

Lung adenocarcinoma with bronchio-alveolar carcinoma component frequently associates foci of high grade atypical adenomatous hyperplasia. International journal

Koga T, Hashimoto S, Yonemitsu Y, Sugio K, Matsuo Y, Mojtahedzadeh S, Yoshino I, Fujii H, Sugimachi K, Sueishi K.

American Journal of Clinical Pathology   117 ( 3 )   464 - 470   2002.3

Administration of a decoy against the AP-1 binding site suppresses neointimal thickening in rabbit balloon injured arteries. International journal

Kume M, Komori K, Matsumoto T, Onohara T, Takeuchi K, Yonemitsu Y, Sugimachi K.

Circulation   105 ( 10 )   1226 - 1232   2002.3

Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats.

Yamashita A, Yonemitsu Y, Okano S, Nakagawa K, Nakashima Y, Iwamoto Y, Nagai Y, Hasegawa M, Sueishi K.

The Journal of Immunology   168 ( 1 )   450 - 457   2002.1

Successful and optimized in vivo gene transfer to rabbit carotid artery mediated by electronic pulse. International journal

Matsumoto T, Komori K, Shouji T, Kuma S, KumeM, Yamaoka T, Mori E, Furuyama T, Yonemitsu Y, Sugimachi K.

Gene Therapy   8 ( 15 )   1174 - 1179   2001.8

Heterogenous distribution of p53 immunoreactivity in human lung adenocarcinoma correlates with MDM2 protein expression, rather than with p53 gene mutation. International journal

Koga T, Hashimoto S, Sugio K, Yoshino I, Nakagawa K, Yonemitsu Y, Sugimachi K, Sueishi K.

International Journal of Cancer   2001.7

Clinico-pathological and molecular evidence indicating the independency of bronchio-alveolar components from other subtypes of human lung adenocarcinoma. International journal

Koga T, Hashimoto S, Sugio K, Yoshino I, Mojtahedzadeh S, Matsuo Y, Yonemitsu Y, Sugimachi K, Sueishi K.

Clinical Cancer Research   7 ( 6 )   1730 - 1738   2001.6

Recombinant Sendai Virus-mediated Gene Transfer to Vasculature: a new class of efficient gene transfer vector to the vascular system. International journal

Masaki I, Yonemitsu Y, Komori K, Ueno H, Nakashima Y, Nakagawa K, Fukumura M, Kato A, Hasan MK, Nagai Y, Sugimachi K, Hasegawa M, Sueishi K.

The FASEB Journal   15 ( 7 )   1294 - 1296   2001.5

Dual action of ZD6169, a novel K+ channel opener, on ATP-sensitive K+ channels in pig urethral myocytes. International journal

Teramoto N, Yunoki T, Takano M, Yonemitsu Y, Masaki I, Sueishi K, Brading AF Ito Y.

British Journal of Pharmacology   133 ( 1 )   154 - 164   2001.5

Preclinical and therapeutic utility of HVJ-liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex thymidine kinase. International journal

Hasegawa H, Shimada M, Yonemitsu Y, Utsunomiya T, Gion T, Kaneda Y, Sugimachi K.

Cancer Gene Therapy   8 ( 4 )   252 - 258   2001.4

Non-penetrating vascular clips anastomosis inhibited intimal thickening under poor runoff conditions in canine autogenous vein grafts International journal

Komori K, Shoji T, Furuyama T, Yonemitsu Y, Mori E, Yamaoka T, Matsumoto T, Sugimachi K.

European Journal of Vascular and Endovascular Surgery   21 ( 3 )   241 - 247   2001.3

Immunohistochemical phenotypic alterations of rabbitt autologous vein grafts implanted under arterial circulation with or without poor distal runoff -implications of vein graft remodeling. International journal

Ishida M, Komori K, Yonemitsu Y, Matsumoto T, Onohara T, Sugimachi K.

Atherosclerosis   154 ( 2 )   345 - 354   2001.2

The effects of caffeine on ATP-sensitive K+ currents in smooth muscle cells from pig urethra. International journal

Teramoto N, Yunoki T, Tanaka K, Takano M, Masaki I, Yonemitsu Y, Sueishi K, Ito, Y.

British Journal of Pharmacology   131 ( 3 )   505 - 513   2000.10

Efficient gene transfer to the airway epithelium using recombinant Sendai virus. International journal

Yonemitsu Y, Kitson C, Ferrari S, Farley R, Griesenbach U, Dian J, Steel R, Phillipe S, Zhu J, Jeffery PK, Kato A, Hasan MK, Masaki I, Nagai Y, Fukumura M, Hasegawa M, Geddes DM, Alton EWFW.

Nature Biotechnology   18 ( 9 )   970 - 973   2000.9

The proliferative properties of tumor cells differentially correlate with the host immune responses in anogenital Bowen's disease. International journal

Duan H, Imafuku S, Yonemitsu Y, Yasumoto S, Koga T, Nagae S, Kiryu H, Imayama S, Sueishi K, Hori Y, Furue M.

Journal of Dermatological Science   20 ( 1 )   53 - 62   1999.5

Heterogenous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection. International journal

Namoto M, Yonemitsu Y, Nakagawa K, Hashimoto S, Kaneda Y, Nawata H, Sueishi K.

International Journal of Oncology   12 ( 4 )   777 - 784   1998.4

Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. International journal

Yonemitsu Y, Tanaka S, Kaneda Y, Nakashima Y, Komori K, Sugimachi K, Sueishi K.

Circulation Research   82 ( 2 )   147 - 156   1998.2

HVJ-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff.

Matsumoto T, Komori K, Yonemitsu Y, Morishita R, Kaneda Y, Suieshi K, Sugimachi K.

Journal of Vascular Surgery   1998.1

Acceleration of impairment of endothelium-dependent responses under poor runnoff conditions in canine autogenous vein grafts. International journal

Komori K, Yamamura S, Ishida M, Matsumoto T, Kuma S, Eguchi D, Yonemitsu Y, OnoharaT, Sugimachi K.

Europian Journal of Vascular and Endovascular Surgery   14 ( 6 )   475 - 481   1997.12

Vasculoprotective role of inducible nitric oxide synthase at coronary inflammatory lesions induced by chronic treatment with interleukin-1β in pigs in vivo. International journal

96 ( 9 )   3104 - 3111   1997.11

Enhancement of nitric oxide production after arterial reconstruction in patients with arteriosclerosis obliterans. International journal

Komori K, Matsumoto T, Ishida M, Kuma S, Yonemitsu Y, Eguchi D, Sugimachi K.

Journal of Vascular Surgery   26 ( 4 )   657 - 662   1997.10

Preserved endothelial function and morphology in canine arterial grafts under conditions of poor distal runoff. International journal

Wei C, Komori K, Mawatari K, Yonemitsu Y, Sugimachi K.

Journal of Surgical Research   71 ( 2 )   117 - 122   1997.8

HVJ (Sendai virus) cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium. International journal

Yonemitsu Y, Kaneda Y, Muraishi A, Yoshizumi T, Sugimachi K, Sueishi K.

Gene Therapy   4 ( 7 )   631 - 638   1997.7

The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo. International journal

Yonemitsu Y, Kaneda Y, Komori K, Hirai K, Sugimachi K, Sueishi K.

Biochemical and Biophysical Research Communications   231 ( 2 )   447 - 451   1997.2

Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. International journal

Fukumoto Y, Shimokawa H, Ito A, Kadokami T, Yonemitsu Y, Aikawa M, Owada K, Egashira K, Sueishi K, Nagai R, Yazaki Y, Takeshita A.

Journal of Cardiovascular Pharmacology   29 ( 2 )   222 - 231   1997.2

Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (HVJ)-liposomes: an effective tool for the in vivo study of arterial diseases. International journal

Yonemitsu Y, Kaneda Y, Morishita R, Nakagawa K, Nakashima Y, Sueishi K.

Laboratory Investigation   75 ( 3 )   313 - 323   1996.9

In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. International journal

Yonemitsu Y, Nakagawa K, Tanaka S, Mori R, Sugimachi K, Sueishi K.

Laboratory Investigation   74 ( 4 )   723 - 736   1996.4

（増刊）日本臨床：関節リウマチ - 成因の研究から治療の新時代へ - III. 関節リウマチの成因と病態生理：炎症メディエーター・サイトカイン　血管新生因子

山下彰久、米満吉和

2005.1 

（増刊号）実験医学『血管研究の最先端と治療への展開』 第２章　血管病態の分子メカニズム　３．FGF-2による血管新生因子群の階層的発現制御機構 - 機能を持つ血管の再生システム

藤井孝明、米満吉和

羊土社  2004.5 

（単行本）『遺伝子治療フロンティア』（外科遺伝子治療研究会編） 第１章　 遺伝子治療ベクター　−up to date− 組み換えセンダイウイルスベクタ−：改変型ベクタ−と臨床応用の現状

柴田智子、長谷川護、米満吉和

メディカルレビュー社  2004.4 

『血管炎』（長澤俊彦監修、橋本博史編） III. 血管炎の理解のために。9. 血管炎における血管閉塞の機序 １）内膜肥厚の観点から。

米満吉和、居石克夫（ Role： Sole author）

朝倉書店  2001.1 

『血管内科』（江頭健輔、久米典昭、倉林正彦、栗原裕基、堀内正嗣、森下竜一編） 第２章　血管生物学の基礎 １．血管壁の構成細胞

米満吉和、居石克夫（ Role： Sole author）

メディカルレビュー社  2001.1 

『血管新生研究の新展開』（室田誠逸、佐藤靖史編）

米満吉和、居石克夫（ Role： Sole author）

医薬ジャーナル社  2000.1 

『血管における生命現象の分子生物学』（森下竜一編）． 第１章　血管の機能解析のための新しい分子生物学的手法． 形態学的解析　-病理学の立場から

米満吉和、居石克夫（ Role： Sole author）

メディカルレビュー社  2000.1 

A New Strategy for Angiogenic Gene Therapy in Use of Recombinant Sendai Virus and FGF-2. Invited

Yonemitsu Y.

Seminar at AGCT Gene Technology Co. Ltd.  2003.8 

Contribution of Vascular Progenitors/ Stem Cells in Atherogenesis and Angiogenesis: real players or just an illusion?

2003.9 

Harmonized and Hierarchical Actions of Angiogenic Growth Factors for Functional and Therapeutic Neovascularization. Invited International conference

Yonemitsu Y.

The International Synposium on Atherosclerotic Vascular Diseases  2003.10 

FGF-2による階層的血管新生制御メカニズム

米満吉和

第４４回日本脈管学会総会  2003.11 

血管新生因子群の相互調節的発現制御機構が規定する「機能的」および「病的」

米満吉和

九大リサーチコア・P&P 血管病セミナー  2003.11 

血管新生・再生の各時相における、増殖因子群の役割：FGF-2を中心にして

米満吉和

2003.12 

センダイウイルスベクターによる遺伝子治療臨床研究計画

米満吉和

第２６回日本分子生物学会総会  2003.12 

サルを用いた遺伝子治療開発研究

米満吉和

国立感染症研究所学友会シンポジウム  2003.12 

FGF-2による『機能的』血管新生過程における血管新生因子の階層的発現制御機構

米満吉和

日本皮膚科学会  2004.2 

FGF-2による『機能的』血管新生過程における血管新生因子の階層的発現制御機構

米満吉和

第１回血管病研究会  2004.2 

悪性腹水を伴うマイクロサテライト安定(MSS)性進行胃/膵癌患者を対象としたGAIA-102の反復腹腔内投与に関する第I/II相臨床試験(Phase I/II clinical trial of repeated intraperitoneal administration of GAIA-102 in patients with microsatellite stable(MSS) advanced gastric/pancreatic cancer with malignant ascites)

Ota Mitsuhiko, Oki Eiji, Hu Qingjiang, Ito Shinji, Eto Shohei, Kawazoe Tetsuro, Tajiri Hirotada, Zaitsu Yoko, Nakanishi Ryota, Nakashima Yuichiro, Morodomi Yosuke, Yoshizumi Tomoharu, Yonemitsu Yoshikazu

日本癌治療学会学術集会抄録集  2023.10  (一社)日本癌治療学会

胃癌/膵癌を対象としたGAIA-102の腹腔内投与の第I/II相試験(Phase I/II trial of intraperitoneal infusion of GAIA-102 for gastric/pancreatic cancer)

Oki Eiji, Ota Mitsuhiko, Kawazoe Tetsuro, Tajiri Hirotada, Zaitsu Yoko, Nakanishi Ryota, Nakashima Yuichiro, Morodomi Yosuke, Harada Yui, Yoshizumi Tomoharu, Yonemitsu Yoshikazu

日本胃癌学会総会記事  2024.2  (一社)日本胃癌学会

特集：閉塞性動脈硬化症に対する血管新生療法

鬼丸満穂、米満吉和

2003.1

特集：遺伝子治療の方向性 - 新たな治療ベクターへの挑戦

飯田章博、米満吉和、長谷川護

分子細胞治療   2003.1

特集：心血管系における細胞療法・遺伝子療法の現状と展望

米満吉和

循環器科   2003.1

特集：遺伝子治療〜新たな戦略〜

米満吉和

ゲノム医学   2003.1

Angiogenesis and its regulation: roles of vascular endothelial cell growth factor.

Nakagawa K, Chen Y-X, Ishibashi H, Yonemitsu Y, Murata T, Hata Y, Nakashima Y, Sueishi K.

Semin Thromb Hemost   2002.1

組換えセンダイウイルスベクターを用いた血管壁への遺伝子導入．

庄司文裕、長谷川護、米満吉和

脳と循環   2002.1

特集「大動脈炎症候群をどう診るか」

米満吉和、居石克夫

2002.1

Suggestion：「機能的」血管新生療法の確立に向けて。

米満吉和、居石克夫

治療学   2002.1

血管新生遺伝子治療における「血管新生因子作用機構の階層性」と「Integrated Therapeutic Angiogenesis」の提唱．

米満吉和、長谷川護、居石克夫

脈管学   2002.1

特集「血液細胞と血管新生」

山下彰久、米満吉和、居石克夫

血液フロンティア   2002.1

特集：遺伝子治療- 現状とその近未来。

宮崎勝徳、長谷川　護、伊東啓行、米満吉和

2002.1

「医学研究再入門」第５回：個体レベルの遺伝子導入

池田康博、長谷川　護、米満吉和

分子心血管病   2002.1

Gene Therapy in Vascular Surgery Comes of Age.

Yonemitsu Y, Komori K, Sueishi K, Sugimachi K.

Surgery   2002.1

Gene targeting to the retina.

Sakamoto T, Ikeda Y, Yonemitsu Y.

Adv Drug Deliv Rev   2001.10

網膜への遺伝子ターゲティング（Gene Targeting to Retina）

坂本泰二、池田康博、米満吉和．

あたらしい眼科   2001.1

Trend Paper：組換えセンダイウイルスベクターによる遺伝子治療：

真崎一郎、長谷川　護、米満吉和．

バイオ・ベンチャー   2001.1

わだい：サイトメガロウイルスと動脈硬化

米満吉和、居石克夫．

2001.1

血管壁細胞の遺伝子発現制御と治療への応用

居石克夫、米満吉和、中川和憲、中島　豊．

脈管学   2001.1

ウイルス感染と大型血管炎

米満吉和、居石克夫．

脈管学   2001.1

Gene targeting to the retina

Sakamoto T, Ikeda Y, Yonemitsu Y.

Adv Drug Deliv Rev   2001.1

Angiogenesis and its regulation: roles of vascular endothelial cell growth factor.

Nakagawa K, Chen Y-X, Ishibashi H, Yonemitsu Y, Murata T, Hata Y, Nakashima Y, Sueishi K.

Semin Thromb Hemost   2000.1

シンポジウム「動脈硬化と炎症」

米満吉和、居石克夫．

動脈硬化   2000.1

特集：循環器疾患への遺伝子治療．

真崎一郎、米満吉和．

医学のあゆみ   2000.1

特集：分子診療の現状と将来．

米満吉和、古森公浩．

分子心血管病   2000.1

特集：血管炎の基礎と臨床

米満吉和、居石克夫．

最新医学   2000.1

Regarding "detection of active cytomegalovirus infection in inflammatory abdominal aortic aneurysms with RNA polymerase chain reaction."

Yonemitsu Y, Komori K, Sugimachi K.

1999.7

Regarding "detection of active cytomegalovirus infection in inflammatory abdominal aortic aneurysms with RNA polymerase chain reaction."

Yonemitsu Y, Komori K, Sugimachi K.

J Vasc Surg   1999.1

特集：第２世代に入った遺伝子治療　- 心血管系の遺伝子治療 -

古森公浩、米満吉和、杉町圭蔵

1999.1

特集：イオンチャンネルと疾患　２３）イオンチャンネル病の遺伝子治療

米満吉和、金田安史、Eric WFW Alton．

現代医療   1999.1

HVJ liposome-mediated gene transfer: current status and future perspectives.

Yonemitsu Y, Alton EWFW, Komori K, Yoshizumi T, Sugimachi K, Kaneda Y.

Intl J Oncol   1998.6

Viruses and vascular disease.

Yonemitsu Y

Nature Med   1998.3

動脈硬化と外因性凝固

中川和憲、市川晃治、加藤和彦、米満吉和、中島　豊、居石克夫

動脈硬化   1998.1

特集：ヒトβヘルペスウイルスとHHV6, 7　持続感染と発症機構　ヒト血管病変におけるサイトメガロウイルス感染とその意義

米満吉和、古森公浩、居石克夫、杉町圭蔵

日本臨床   1998.1

ヒト血管病変におけるサイトメガロウイルス感染とその意義

居石克夫、米満吉和

遺伝子医学   1998.1

HVJ liposome-mediated gene transfer: current status and future perspectives.

Yonemitsu Y, Alton EWFW, Komori K, Yoshizumi T, Sugimachi K, Kaneda Y.

Intl J Oncol   1998.1

Viruses and vascular disease.

Yonemitsu Y.

Nature Med   1998.1

Atherosclerosis and angiogenesis: its pathophisiological significance in humans as well as in animal model induced by gene transfer of vascular endothelial growth factor.

Sueishi K, Yonemitsu Y, Nakagawa K, Kaneda Y, Kumamoto M.

Ann NY Acad Sci   1997.4

Wild-type p53 gene transfer: a novel therapeutic strategy for neointimal hyperplasia after arterial injury.

Yonemitsu Y, Kaneda Y, Hata Y, Nakashima Y, Sueishi K.

Ann NY Acad Sci   1997.4

Elucidation of the function of the new NK cell subset and its application to adoptive immunotherapy

Grant number：21H04832  2021 - 2023

Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (A)

Development of a completely new antibody-cell complex advanced technology that overcomes the limitations of allogeneic CAR-T therapy.

Grant number：21K19529  2021 - 2022

Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Challenging Research(Exploratory)

Yonemitsu Yoshikazu

医工連携によるミニチュアヒト肝臓創成とそのex vivo培養がもたらす革新的医療

Grant number：20H03744  2020.4 - 2023.3

科学研究費助成事業  基盤研究(B)

山下 洋市, 井嶋 博之, 馬場 秀夫, 米満 吉和, 相島 慎一

我々が新しく発見したNK細胞subsetの機能解明と養子免疫治療への応用

Grant number：18H04060  2018 - 2020

日本学術振興会  科学研究費助成事業  基盤研究(A)

Sphere破壊能を指標とした難治性悪性腫瘍に対する薬剤スクリーニングの創成

Grant number：16K15619  2016 - 2017

科学研究費助成事業  挑戦的萌芽研究

高性能国産新規ＲＮＡウイルスベクターによる虚血肢治療製剤の開発(2014年度 総括)

2013 - 2016

厚生労働科学研究費補助金 (厚生労働省）

新しい概念に基づく遺伝子操作マウス創出基盤の確立

Grant number：25670176  2013 - 2015

科学研究費助成事業  挑戦的萌芽研究

腹膜播種細胞が足場とするニッシェ様細胞の同定とその標的化による治療技術の開発

Grant number：25293286  2013

日本学術振興会  科学研究費助成事業  基盤研究(B)

難治性悪性腫瘍根絶へ向けた免疫賦活RNAウイルス療法の体系化基盤研究

Grant number：21390364  2009 - 2011

日本学術振興会  科学研究費助成事業  基盤研究(B)

染色体遺伝子へ影響を与えない全く新しい遺伝子操作マウス創出技術の確立

Grant number：21659097  2009 - 2010

科学研究費助成事業  挑戦的萌芽研究

文部科学省「橋渡し研究支援推進プログラム」：九州大学拠点「革新的バイオ医薬医工学の医療技術開発拠点」

2008.4 - 2012.3

国産新規ウイルスベクターを用いた重症虚血肢に対する新GCP準拠遺伝子治療臨床研究

2006 - 2008

厚生労働科学研究費補助金 (厚生労働省）

血管新生病の分子基盤の解明:動物モデルとヒトの病変解析の統合研究

Grant number：18390115  2006 - 2007

日本学術振興会  科学研究費助成事業  基盤研究(B)

細胞質転写型新規国産ベクターを用いた染色体非傷害型免疫再構築遺伝子治療法の開発

Grant number：16659094  2004 - 2005

科学研究費助成事業  萌芽研究

時間軸から見た生体内における血管新生プロセスの高次機能解析

Grant number：16390118  2004 - 2005

日本学術振興会  科学研究費助成事業  基盤研究(B)

生体内での『機能的』血管新生過程における細胞・分子間作用階層構造の解明：生体内遺伝子導入法による個体での検証

Grant number：14370072  2002 - 2003

日本学術振興会  科学研究費助成事業  基盤研究(B)

組み換え型センダイウイルスベクターによる遺伝子治療系の確立とその臨床応用：国産新規遺伝子導入ベクターによる世界初の遺伝子治療臨床応用を目指して

Grant number：12557020  2000 - 2002

日本学術振興会  科学研究費助成事業  基盤研究(B)

ヒトサイトメガロウイルス前早期遺伝子による血管病変形成機序の解明・トランスジェニックマウスと組み換えウイルスによるアプローチ

Grant number：12470057  2000 - 2001

日本学術振興会  科学研究費助成事業  基盤研究(B)